NL-OMON53695招募中不适用
SerUM markers in MERkel Cell Carcinoma patients: a longitudinal moniTorIng study for optiMization of European guidelines. - SUMMERTIME
niversity Hospital Center of Tours0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1) Patients with a « de novo » diagnosis of MCC, confirmed on
- •histological criteria (neuroendocrine morphology, CK20 staining
- •and/or neuroendocrine and/or SATB2 staining, exclusion of
- •differential diagnosis)
- •2) >= 18 years of age
- •3) Written informed consent obtained from the participant
排除标准
- •1) Patients following any measures of legal presentation
- •2) Pregnancy or breastfeeding
研究者
相似试验
进行中（未招募）
不适用
SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European GuidelinesMerkel Cell CarcinomaNCT04705389University Hospital, Tours35
进行中（未招募）
不适用
Blood testing to predict good response to chemotherapyCTRI/2020/10/028763AIIMS
已完成
不适用
CA209-759: Blood-borne biomarkers for tumor response to Nivolumab in KRAS-mutated non-small cell lung cancer, an exploratory studyNon-small cell lung cancer (NSCLC)10038666NL-OMON45880niversitair Medisch Centrum Groningen40
尚未招募
不适用
CA209-759: Blood-borne biomarkers for tumor response to Nivolumab in KRAS-mutated non-small cell lung canceron-small cell lung cancer, KRAS mutationNiet-kleincellig longkanker, KRAS mutatieNL-OMON25545niversity Medical Center Groningen40
Enrolling By Invitation
不适用
Correlation between serum squamous cell carcinoma antigen level and c-reactive protein with tumor volume in oral cavity cancerAdult patients (18-80 years) with oral cavity squamous cell carcinomaSquamous cell carcinoma antigen, CRP, Tumor volume, Oral cavity cancerTCTR20211002001/A30